For the Inventor, By the Inventor

Enter assignee name

Zug, Switzerland

Lupin Atlantis Holdings Sa

USPTO Granted Patents = 13

EPO Patents = 3

Trademarks = 6

Forward Citations = 41

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Sanjeev Anant Kulkarni (4 out of 15 patents)

Rajender Kumar Kamboj (4 out of 46 patents)

Venkata Poornapragnacharyulu Palle (4 out of 104 patents)

4. Manojkumar Ramprasad Shukla (3 out of 9 patents)

5. Bala Chandran Nayar (3 out of 4 patents)

6. Mahadeo Bhaskar Tryambake (3 out of 7 patents)

7. Ankush Gangaram Sarde (2 out of 5 patents)

8. Chetan Sanjay Pawar (2 out of 5 patents)

9. Alfred Von Schuckmann (1 out of 70 patents)

10. Franciscus Koppenhagen (1 out of 7 patents)

11. Abhishek Gupta (1 out of 1 patent)

12. Herbert Clark Chiou (1 out of 1 patent)

13. Samiran De (1 out of 1 patent)

14. Xian-Ming Zeng (1 out of 1 patent)

15. Vishwajit Bhide (1 out of 5 patents)

13 patents: Sort by Forward Citations

1. 10617646 - Process for manufacturing dry powder blends (2020-04-14),

2. 9687549 - Topical pharmaceutical gel composition of diclofenac sodium (2017-06-27),

3. D789517 - Inhaler (2017-06-13),

4. D785164 - Bowel preparation bag (2017-04-25),

5. 9598391 - Substituted chroman compounds as calcium sensing receptor modulators (2017-03-21),

6. 9598371 - Arylalkylamine compounds as calcium sensing receptor modulators (2017-03-21),

7. 9493396 - Substituted naphthalene compounds as calcium sensing receptor modulators (2016-11-15),

8. 9468618 - Topical pharmaceutical gel composition of diclofenac sodium (2016-10-18),

9. 9468617 - Topical pharmaceutical gel composition of diclofenac sodium (2016-10-18),

10. 9464063 - Benzo [B] [1,4] oxazin derivatives as calcium sensing receptor modulators (2016-10-11),

11. 9314447 - Reduced dose pharmaceutical compositions of fenofibrate (2016-04-19),

12. D739522 - Inhaler (2015-09-22),

13. 8026281 - Treating metabolic syndrome with fenofibrate (2011-09-27),

Lupin Atlantis Holdings Sa is a global pharmaceutical company that specializes in developing and manufacturing innovative drugs. With a focus on improving patients' lives, Lupin Atlantis is committed to delivering high-quality and affordable medicines. The company's diverse portfolio includes medications for various therapeutic areas such as cardiovascular, respiratory, and central nervous system disorders. Lupin Atlantis' cutting-edge research and development facilities contribute to its reputation as a leader in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

13 Patents

#43 in Zug

#848 in Switzerland

#43,615 in the World

Zug, Switzerland

Lupin Atlantis Holdings Sa

Forward Citations = 41

43 inventors:

Sanjeev Anant Kulkarni (4 out of 15 patents)

Rajender Kumar Kamboj (4 out of 46 patents)

Venkata Poornapragnacharyulu Palle (4 out of 104 patents)

4. Manojkumar Ramprasad Shukla (3 out of 9 patents)

5. Bala Chandran Nayar (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…